Stay updated with breaking news from Single Pill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
14.02.2023 - EQS-News: APONTIS PHARMA AG / Key word(s): Product Launch APONTIS PHARMA accelerates expansion of Single Pill portfolio with second of three in-licensing deals planned for 2023 14.02.2023 / 07:30 CET/CEST The issuer is solely responsible for the ... Seite 1
EQS-News: APONTIS PHARMA AG / Key word(s): Product Launch APONTIS PHARMA extends portfolio for the treatment of hypertension and hype...
EQS-News: APONTIS PHARMA AG / Key word(s): Product LaunchAPONTIS PHARMA extends portfolio for the treatment of hypertension and hyperlipidemia by in-licensing a new Single Pill 31.01.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.APONTIS PHARMA extends portfolio for the tr...
EQS-News: APONTIS PHARMA AG / Key word: 9 Month figures/Quarterly / Interim Statement APONTIS PHARMA confirms 2022 forecast after successful nine-month period – Strong Single Pill... | November 10, 2022
EQS-News: APONTIS PHARMA AG / Key word(s): Alliance/Product Launch APONTIS PHARMA announces cooperation to launch new Single Pill in ...